Healthcare provider profile · identity verified

Jeffrey Cal Berry, M.D

Family Practice · KANSAS CITY, MO · NPI 1790219210

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	841	242
Amlodipine Besylate	Amlodipine Besylate	473	142
Lisinopril	Lisinopril	369	109
Levothyroxine Sodium	Levothyroxine Sodium	360	104
Losartan Potassium	Losartan Potassium	329	96
Pantoprazole Sodium	Pantoprazole Sodium	263	83
Rosuvastatin Calcium	Rosuvastatin Calcium	245	69
Omeprazole	Omeprazole	230	71
Metoprolol Succinate	Metoprolol Succinate	206	53
Meloxicam	Meloxicam	175	67
Carvedilol	Carvedilol	168	45
Metformin Hcl	Metformin Hcl	166	47
Metformin Hcl Er	Metformin Hcl	153	41
Gabapentin	Gabapentin	128	51
Tamsulosin Hcl	Tamsulosin Hcl	125	46
Metoprolol Tartrate	Metoprolol Tartrate	117	32
Hydrochlorothiazide	Hydrochlorothiazide	116	35
Escitalopram Oxalate	Escitalopram Oxalate	107	35
Albuterol Sulfate Hfa	Albuterol Sulfate	102	50
Lovastatin	Lovastatin	102	29
Alendronate Sodium	Alendronate Sodium	88	27
Potassium Chloride	Potassium Chloride	88	30
Prednisone	Prednisone	84	68
Trazodone Hcl	Trazodone Hcl	83	29
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	82	82
Citalopram Hbr	Citalopram Hydrobromide	79	23
Doxycycline Hyclate	Doxycycline Hyclate	75	74
Warfarin Sodium	Warfarin Sodium	75	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	74	43
Simvastatin	Simvastatin	73	21
Furosemide	Furosemide	71	20
Montelukast Sodium	Montelukast Sodium	71	23
Pravastatin Sodium	Pravastatin Sodium	70	22
Zolpidem Tartrate	Zolpidem Tartrate	69	14
Jardiance	Empagliflozin	68	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	67	19
Ezetimibe	Ezetimibe	66	19
Eliquis	Apixaban	63	15
Shingrix	Varicella-Zoster Ge/As01b/Pf	62	50
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	60	57
Famotidine	Famotidine	55	17
Tramadol Hcl	Tramadol Hcl	54	16
Allopurinol	Allopurinol	50	12
Sertraline Hcl	Sertraline Hcl	50	14
Glipizide Er	Glipizide	49	20
Methylprednisolone	Methylprednisolone	46	45
Fluticasone Propionate	Fluticasone Propionate	45	16
Cephalexin	Cephalexin	44	38
Naproxen	Naproxen	44	31
Celecoxib	Celecoxib	41	13
Chlorthalidone	Chlorthalidone	41	13
Finasteride	Finasteride	41	11
Buspirone Hcl	Buspirone Hcl	37	11
Clopidogrel	Clopidogrel Bisulfate	37	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	37	14
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	33	33
Paxlovid	Nirmatrelvir/Ritonavir	33	33
Hydroxyzine Hcl	Hydroxyzine Hcl	32	19
Synthroid	Levothyroxine Sodium	32	suppressed
Mounjaro	Tirzepatide	31	suppressed
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	30	suppressed
Ozempic	Semaglutide	30	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Bupropion Xl	Bupropion Hcl	29	suppressed
Xarelto	Rivaroxaban	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	21
Duloxetine Hcl	Duloxetine Hcl	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	24
Irbesartan	Irbesartan	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Valsartan	Valsartan	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Mupirocin	Mupirocin	19	18
Valacyclovir	Valacyclovir Hcl	19	suppressed
Atenolol	Atenolol	18	suppressed
Azithromycin	Azithromycin	18	17
Clonidine Hcl	Clonidine Hcl	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Rizatriptan	Rizatriptan Benzoate	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Ondansetron Odt	Ondansetron	17	16
Trulicity	Dulaglutide	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	suppressed
Colestipol Hcl	Colestipol Hcl	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	12
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Ciclopirox	Ciclopirox	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error